The Outcomes of Family Haploidentical Hematopoietic Stem Cell Transplantation in Hematologic Malignancies Are Not Associated with Patient Age Lujia Dong, Tong Wu, Zhi-Yong Gao, Mei-Jie Zhang, Fangyu Kan, Stephen R. Spellman, Xi-You Tan, Yan-Li Zhao, Jing-Bo Wang, Dao- Pei Lu, David Miklos, Effie Petersdorf, Marcelo Fernandez-Vina, Stephanie J. Lee Biology of Blood and Marrow Transplantation Volume 17, Issue 8, Pages 1205-1213 (August 2011) DOI: 10.1016/j.bbmt.2010.12.703 Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 1 (A) Cumulative incidence of TRM, (B) cumulative incidence of relapse, (C) adjusted probability of LFS, and (D) adjusted probability of OS (adults versus children with no TCD/with TCD) from CIBMTR cohort. TED indicates T cell depletion ex vivo; TRM, treatment-related mortality; LFS, leukemia-free survival; OS, overall survival. Biology of Blood and Marrow Transplantation 2011 17, 1205-1213DOI: (10.1016/j.bbmt.2010.12.703) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions
Figure 2 (A) Cumulative incidence of TRM, (B) cumulative incidence of relapse, (C) adjusted probability of LFS, and (D) adjusted probability of OS (adults versus children) from the Dao-Pei cohort. TRM indicates treatment-related mortality; LFS, leukemia-free survival; OS, overall survival. Biology of Blood and Marrow Transplantation 2011 17, 1205-1213DOI: (10.1016/j.bbmt.2010.12.703) Copyright © 2011 American Society for Blood and Marrow Transplantation Terms and Conditions